Francoise Derouane

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Journal: Cancers
Published: September 09, 2025

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Journal: medRxiv : the preprint server for health sciences
Published: March 17, 2025

Jacaric Acid Empowers RSL3-Induced Ferroptotic Cell Death in Two- and Three-Dimensional Breast Cancer Cell Models.

Jacaric Acid Empowers RSL3-Induced Ferroptotic Cell Death in Two- and Three-Dimensional Breast Cancer Cell Models.

Journal: International journal of molecular sciences
Published: February 03, 2025

Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Journal: Nature communications
Published: January 02, 2025

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Journal: ESMO open
Published: March 22, 2024

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial-mesenchymal transition and tumor-infiltrating lymphocytes.

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial-mesenchymal transition and tumor-infiltrating lymphocytes.

Journal: Molecular oncology
Published: March 22, 2024

Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers.

Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers.

Journal: Breast cancer research : BCR
Published: August 08, 2023

Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice.

Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice.

Journal: Cancers
Published: September 10, 2022

Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.

Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.

Journal: Cancers
Published: July 11, 2022

MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice.

MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice.

Journal: Cancers
Published: January 10, 2022

Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients.

Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients.

Journal: Scientific reports
Published: December 16, 2020

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

Journal: BMC cancer
Published: October 06, 2020
Showing 1-12 of 16

Last Updated: 09/26/2026